期刊文献+

心肾综合征患者心脏结构功能、BNP、Cys-C变化与CKD分期的相关性 被引量:4

Association of changes of heart structure and brain natriuretic peptide and cystatin C levels with chronic kidney disease staging in patients with cardiorenal syndrome
下载PDF
导出
摘要 目的:探讨心肾综合征(cardiorenal syndrome,CRS)患者超声心动图变化及全血脑钠肽(brain natriuretic peptide,BNP)、胱抑素C(Cystatin C,Cys-C)水平等与慢性肾脏病(chronic kidney disease,CKD)分期的关系。方法:我院肾内科符合标准的84例CRS患者,检测入院时的全血BNP、Cys-C水平,并检测超声心动图及心电图,收集相关参数进行分析。结果:CKD3、4、5期CRS患者之间,全血BNP、Cys-C水平有显著差异,各组之间左室舒张末期内径(LVDd)、左室后壁厚度(LVPW)、E峰、E/A、心率差异有统计学意义(P〈0.05),而BNP和LVDd与CKD分期的相关性更加密切。结论:CKD 3-5期CRS患者心脏结构改变主要表现在左室舒张末期内径、左室后壁厚度增加等,心功能障碍主要表现在舒张功能受累。联合全血BNP、Cys-C水平、超声心动图及心电图检查可以作为观察CRS病情的有效指标,有利于预防及早期治疗。 Objective: To explore the relationship between the staging of chronic kidney disease( CKD) and changes of heart structure and brain natriuretic peptide( BNP) and cystatin C( Cys-C) in patients with cardiorenal syndrome( CRS). Methods: Total of 84 eligible patients with CKD were included between January 2011 and June 2012. All patients were undergone determination of whole blood BNP and cys-C levels as well as echocardiogram and electrocardiogram examination at admission. The data were gathered for analysis of the relationship among the indicators. Results: Of the patients in stage of CKD3,4 and 5,the BNP and cys-C levels,left ventricular end diastolic diameter( LVDd),left ventricular posterior wall thickness( LVPW),and flow velocity at peak E and E / A ratio were statistically different( P 0. 01). Conclusion: CRS patients in stage CKD 3 to 5 primarily demonstrated LVDd change and thickened posterior left ventricular wall and diastolic function impairment. Combined determination of whole blood BNP and cys-C with echocardiogram and electrocardiogram examination may be effective indicators for prevention and early treatment of this disease.
出处 《皖南医学院学报》 CAS 2015年第1期26-29,共4页 Journal of Wannan Medical College
关键词 心肾综合征 脑钠肽 胱抑素C 超声心动图 cardiorenal syndrome brain natriuretic peptide cystatin C color doppler ultrasound
  • 相关文献

参考文献16

  • 1Ronco C,McC ullough P,Anker SD,et al.Cardio-renal syndromes:report from the consensus conference of the acute dialysis quality initiative[J].Eur Heart Jour,2010,31(6):703-711.
  • 2Ronco C,Haapio M,HDu Se AA,et al.Cardiorenal syndrome[J].J Am Coll Cardiol,2008,52(19):1527-1539.
  • 3Kosaku Nitta.Pathogenesis and therapeutic implications of cardiorenal syndrome[J].Clin Exp Nephrol,2011,15(2):187-194.
  • 4Shrestha K,Tang WH.Cardiorenal syndrome:diagnosis,treatment,and clinical outcomes[J].Curr Heart Fail Rep,2010,7(4):167-174.
  • 5Cynda AJ,Andrews L,Josef C,et al.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39(2 Suppl 1):S1-266.
  • 6Eloot S,Van Vlem B,De Meester J.Simple assessment of patient's stage of chronic kidney disease using eG FR-MDRD nomograms[J].Int Urol Nephrol,2012,44(1):207-212.
  • 7宋康兴,卢才义.脑利钠肽在神经内分泌系统和心肌重构中的作用[J].中国全科医学,2009,12(7):614-616. 被引量:24
  • 8Huntley BK,Ichiki T,Sangaralingham SJ,et al.B-type natriuretic peptide and extracellular matrix protein interaction in human cardiac fibroblasts[J].J Cell Physiol,2010,225(1):251-255.
  • 9DeF ilippi C,Van Kimmenade RR,Pinto YM.Amino-terminal proB-type natriuretic peptide testing in renal disease[J].Am J Cardiol,2008,101(3A):82-88.
  • 10Van Kimmenade RR,Januzzi JL Jr,Bakker J A,et al.Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects[J].J Am Coll Cardiol,2009,53(10):884-890.

二级参考文献10

  • 1Steen H,,Futterer S,Merten C,et al.Rela-tive role of NT-pro BNP and cardiac troponin T at96hours for estimation of infarct size and left ventricular function after acute myocardial infarction[].Journal of Cardiovascular Magnetic Resonance.2007
  • 2Drewniak W,Snopek G,Zarukiewicz M,et al.Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with a-cute myocardial infarction[].Kardiologia Polska.2008
  • 3Hobbs RE,Mills RM.Endogenous B-type natriuretic peptide:a limb of the regulatory re-sponse to acutely decompensated heart failure[].Clinical Cardiology.2008
  • 4Huntley BK,Sandberg SM,Noser JA,et al.BNP-induced activation of cGMP in humancardiac fibroblasts:interactions with fibronec-tin and natriuretic peptide receptors[].Journal of Cellular Physiology.2006
  • 5Makikallio K,Rounioja S,Vuolteenaho O,et al.Fetal cardiac natriuretic peptide ex-pression and cardiovascular hemodynamics in endotoxin-induced acute cardiac dysfunction in mouse[].Pediatric Research.2006
  • 6ChiurchiùV,Izzi V,D′Aquilio F,et al.Brain Natriuretic Peptide(BNP)regulates the production of inflammatory mediators in human THP-1macrophages[].Regulatory Peptides.2008
  • 7Ikeda K,Tojo K,Udagawa T,et al.Cellu-lar physiology of rat cardiac myocytes in cardi-ac fibrosis:in vitro simulation using the car-diac myocyte/cardiac non-myocyte co-cul-ture system[].Hypertension Research.2008
  • 8Hori Y,Tsubaki M,Katou A,et al.Eval-uation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis[].Journal of Veterinary Internal Medicine.2008
  • 9Milting H,Ellinghaus P,Seewald M,et al.Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices[].The Journal of Heart and Lung Transplantation.2008
  • 10Vorovich EE,Chuai S,Li M,et al.Com-parison of matrixmetalloproteinase9and brain natriuretic peptide as clinical biomarkers in chronic heart failure[].American Heart Journal.2008

共引文献23

同被引文献34

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部